HealthTree
Foundation
Donate
Log In
Discover more
Video
Cilta-Cel CAR-T for Myeloma: Which Patients Benefit From Earlier Treatment? | IMS 2026
Posted by
HealthTree
• October 15, 2026
Related Content
Video
CARTITUDE-2: Can Earlier Cilta-Cel CAR-T Lead to Long-Term Remission or Cure in Myeloma? | IMS 2026
News
Could CAR T-cell Therapy Treat High-Risk Smoldering Myeloma? Latest Research Results from AACR
Video
Long-term PFS updates on the CARTITUDE-4 Trial | Luciano Costa, MD
Video
Lymphocyte Count Used to Predict Delayed Neurotoxicity in Myeloma CAR-T | Hitomi Hosoya MD #ims25
Video
Could CAR-T Cure Myeloma? | 5-Year CARTITUDE-1 Results Explained | Sundar Jagannath, MBBS | EHA 2025
Video
Treating High-Risk Smoldering Myeloma using CAR-T - CAR-PRISM Study | Omar Nadeem, MD | #ASH24
HealthTree • October 15, 2026 HealthTree HealthTree